HOLDIPHARMA
HOLDIPHARMA, a prominent player in the pharmaceutical industry, is headquartered in Egypt (EG) and operates extensively across the Middle East and North Africa. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, focusing on both prescription and over-the-counter medications. With a diverse portfolio that includes unique formulations and advanced drug delivery systems, HOLDIPHARMA is committed to enhancing patient outcomes. The company has achieved significant milestones, including partnerships with leading healthcare providers and recognition for its contributions to the pharmaceutical sector. As a trusted name in the industry, HOLDIPHARMA continues to drive advancements in healthcare, ensuring quality and accessibility for patients in its operational regions.
DitchCarbon Score
How does HOLDIPHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HOLDIPHARMA's score of 24 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HOLDIPHARMA's reported carbon emissions
HOLDIPHARMA, headquartered in Egypt (EG), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. As HOLDIPHARMA continues to navigate the evolving landscape of climate responsibility, further information on their commitments and initiatives may emerge in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HOLDIPHARMA is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
